RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
-25.07%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.09B
AUM Growth
+$1.09B
(-35%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-9.93%
Top 10 Holdings %
Top 10 Hldgs %
62.57%
Holding
59
New
13
Increased
22
Reduced
11
Closed
12
Top Buys
| 1 |
Q32 Bio
QTTB
|
$26.8M |
| 2 |
Adverum Biotechnologies
ADVM
|
$19.1M |
| 3 |
SI-BONE Inc
SIBN
|
$16.8M |
| 4 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$16.6M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$15.9M |
Top Sells
| 1 |
ProQR Therapeutics
PRQR
|
$51.9M |
| 2 |
PTC Therapeutics
PTCT
|
$46.4M |
| 3 |
CORI
Corium International, Inc.
CORI
|
$34.3M |
| 4 |
Illumina
ILMN
|
$30.3M |
| 5 |
Qiagen
QGEN
|
$29.4M |
Sector Composition
| 1 | Healthcare | 91.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rocket Pharmaceuticals
RCKT
$354M
| $236M | 21.64% | 16,037,486 +1,067,742 | +7% | +$15.7M |
|
2
Arrowhead Research
ARWR
$3.05B
| $66M | 6.06% | 5,316,156 -2,288,069 | -30% | -$28.4M |
|
|
3
PTC Therapeutics
PTCT
$3.92B
| $66M | 6.05% | 1,922,346 -1,353,245 | -41% | -$46.4M |
|
|
DRNA
4
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $63.1M | 5.79% | 5,907,088 +445,964 | +8% | +$4.77M |
|
5
Bristol-Myers Squibb
BMY
$96B
| $49.4M | 4.53% | 950,780 +3,819 | +0.4% | +$199K |
|
6
Regenxbio
RGNX
$451M
| $44.1M | 4.04% | 1,050,245 -408,883 | -28% | -$17.2M |
|
7
LivaNova
LIVN
$3.08B
| $40.5M | 3.72% | 443,036 | – | – |
|
8
Sarepta Therapeutics
SRPT
$1.78B
| $39.9M | 3.66% | 365,911 +51,841 | +17% | +$5.66M |
|
9
Vericel Corp
VCEL
$1.83B
| $39.8M | 3.65% | 2,289,134 +71,218 | +3% | +$1.24M |
|
10
Masimo
MASI
$7.59B
| $36.7M | 3.37% | 342,221 +31,760 | +10% | +$3.41M |
|
|
11
Q32 Bio
QTTB
$20.9M
| $36.5M | 3.35% | 1,633,491 +1,198,574 | +276% | +$26.8M |
|
12
Alnylam Pharmaceuticals
ALNY
$58.5B
| $32M | 2.94% | 439,498 +50,426 | +13% | +$3.68M |
|
|
AGEN
13
Agenus
AGEN
$133M
| $24.1M | 2.21% | 10,135,119 +310,540 | +3% | +$739K |
|
14
Establishment Labs
ESTA
$1.2B
| $22.7M | 2.09% | 848,058 +72,249 | +9% | +$1.94M |
|
|
ACHN
15
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $21.9M | 2.01% | 13,749,383 +153,679 | +1% | +$244K |
|
|
16
Adverum Biotechnologies
ADVM
$64.6M
| $19.7M | 1.81% | 6,256,840 +6,072,019 | +3,285% | +$19.1M |
|
|
17
SI-BONE Inc
SIBN
$719M
| $16.8M | 1.54% | +804,327 | New | +$16.8M |
|
18
Arbutus Biopharma
ABUS
$711M
| $16.6M | 1.52% | 4,335,746 +250,842 | +6% | +$961K |
|
|
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
| $16.6M | 1.52% | +1,095,396 | New | +$16.6M |
|
|
SAGE
20
DELISTED
Sage Therapeutics
SAGE
| $15.9M | 1.46% | +165,990 | New | +$15.9M |
|
21
Assembly Biosciences
ASMB
$190M
| $15.5M | 1.43% | +686,644 | New | +$15.5M |
|
22
Apyx Medical
APYX
$75.3M
| $15.5M | 1.42% | 2,391,898 +156,351 | +7% | +$1.01M |
|
|
MYOK
23
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $14.4M | 1.32% | 294,898 +20,981 | +8% | +$1.03M |
|
|
PRNB
24
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $14.2M | 1.3% | 555,948 -88,500 | -14% | -$2.25M |
|
25
CytomX Therapeutics
CTMX
$336M
| $13.7M | 1.26% | +908,586 | New | +$13.7M |
|